Production (Stage)
Bolt Biotherapeutics, Inc.
BOLT
$5.64
-$0.13-2.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.93% | -12.04% | -27.00% | -19.32% | -10.61% |
| Total Receivables | -12.07% | 90.00% | 112.50% | -77.78% | 50.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 18.03% | -13.48% | -22.02% | -2.53% | 2.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -6.56% | 5.93% | -- | -- | -- |
| Total Current Assets | -16.34% | -11.08% | -25.43% | -19.38% | -10.08% |
|
|
|||||
| Total Current Assets | -16.34% | -11.08% | -25.43% | -19.38% | -10.08% |
| Net Property, Plant & Equipment | -6.78% | 22.51% | -6.09% | -5.29% | -5.11% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.05% | -17.74% | -38.83% | -41.27% | -1.56% |
| Total Assets | -13.82% | -8.87% | -11.95% | -13.10% | -10.57% |
|
|
|||||
| Total Accounts Payable | 1.79% | 1.69% | -43.59% | 18.39% | -25.71% |
| Total Accrued Expenses | -25.11% | -19.99% | 41.81% | -24.26% | -22.23% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.62% | -20.29% | -5.71% | 3.74% | 3.77% |
| Total Finance Division Other Current Liabilities | -9.99% | 12.13% | -32.01% | 158.21% | -13.36% |
| Total Other Current Liabilities | -9.99% | 12.13% | -32.01% | 158.21% | -13.36% |
| Total Current Liabilities | -14.47% | -12.32% | 1.02% | 7.04% | -18.25% |
|
|
|||||
| Total Current Liabilities | -14.47% | -12.32% | 1.02% | 7.04% | -18.25% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.83% | 49.53% | -3.42% | -4.70% | -4.34% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -12.13% | -6.39% | -14.45% | -15.20% | -41.75% |
| Total Liabilities | -7.97% | 13.75% | -2.64% | -1.08% | -17.66% |
|
|
|||||
| Common Stock & APIC | 0.15% | 0.25% | 0.23% | 0.61% | 0.48% |
| Retained Earnings | -2.58% | -3.87% | -3.83% | -5.65% | -2.97% |
| Treasury Stock & Other | -58.76% | -52.68% | 565.91% | -22.22% | -197.30% |
| Total Common Equity | -18.16% | -20.59% | -16.11% | -17.57% | -7.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.16% | -20.59% | -16.11% | -17.57% | -7.61% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.16% | -20.59% | -16.11% | -17.57% | -7.61% |
|
|
|||||